Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England ; volume:13 ; number:1 ; day:12 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
Nature Communications ; 13, Heft 1 (12.12.2022), 1-9, 12.2022

Creator
Kirsebom, Freja Cordelia Møller
Andrews, Nick
Sachdeva, Ruchira
Stowe, Julia
Ramsay, Mary
Lopez Bernal, Jamie
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-022-35168-7
URN
urn:nbn:de:101:1-2023022121183580451153
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kirsebom, Freja Cordelia Møller
  • Andrews, Nick
  • Sachdeva, Ruchira
  • Stowe, Julia
  • Ramsay, Mary
  • Lopez Bernal, Jamie
  • SpringerLink (Online service)

Other Objects (12)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants

Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history

Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine

Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk

Related objects